Dimensional Fund Advisors
ABCL icon

Dimensional Fund Advisors’s AbCellera Biologics ABCL Stock Holding History

Dimensional Fund Advisors’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-179,882
Closed -$532K – 3350
2024
Q2 		$532K Buy
179,882
+1,325
+0.7% +$5.01K ﹤0.01% 3018
2024
Q1 		$809K Buy
178,557
+83,990
+89% +$429K ﹤0.01% 2956
2023
Q4 		$540K Buy
94,567
+5,192
+6% +$24.1K ﹤0.01% 3033
2023
Q3 		$411K Buy
89,375
+1,308
+1% +$7.96K ﹤0.01% 3081
2023
Q2 		$569K Buy
88,067
+3,979
+5% +$27.2K ﹤0.01% 3034
2023
Q1 		$634K Buy
+84,088
New +$764K ﹤0.01% 2994
2022
Q3 		$812K Buy
+82,084
New +$901K ﹤0.01% 2940

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors's ABCL Position: Q3 2024 in Review

Dimensional Fund Advisors sold out of AbCellera Biologics (ABCL) in Q3 2024, closing a stake of 179,882 shares — an estimated $532K sold.

Dimensional Fund Advisors first reported a position in ABCL in Q3 2022 and held it in 7 quarters. The position peaked at $812K in Q3 2022. 139 funds tracked by Wall St. Rank hold ABCL as of Q3 2024.

  • Dimensional Fund Advisors reported no remaining AbCellera Biologics position as of Q3 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 179,882 AbCellera Biologics shares in Q3 2024, an estimated $532K.
  • Dimensional Fund Advisors first reported a position in AbCellera Biologics in Q3 2022 and held it in 7 quarters.
  • Dimensional Fund Advisors's AbCellera Biologics position peaked at $812K in Q3 2022.
  • 139 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2024.

Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.